Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Lingor

Showing results (81-90 of 173) with videos related to

Pageof 18
Sort By:
Frontiers in Aging Neuroscience|October 11, 2021
Detection of Cerebrospinal Fluid Neurofilament Light Chain as a Marker for Alpha-SynucleinopathiesSezgi Canaslan, Matthias Schmitz, Anna Villar-Piqué, et al.
Molecular Therapy. Nucleic Acids|June 3, 2018
miR-182-5p and miR-183-5p Act as GDNF Mimics in Dopaminergic Midbrain NeuronsAnna-Elisa Roser, Lucas Caldi Gomes, Rashi Halder, et al.
ACS Chemical Neuroscience|August 19, 2015
Alpha-Synuclein Regulates Neuronal Levels of Manganese and CalciumTanja Dučić, Eleonora Carboni, Barry Lai, et al.
Brain : a Journal of Neurology|October 23, 2012
Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson's diseaseLars Tönges, Tobias Frank, Lars Tatenhorst, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|April 16, 2022
Blood-based biomarker in Parkinson's disease: potential for future applications in clinical research and practiceLars Tönges, Carsten Buhmann, Stephan Klebe, et al.
Plos One|January 29, 2026
Retrospective analysis of neurofilament-light chain in patients with inflammatory bowel disease - A pilot studyAndreas Wolff, Emily Feneberg, Julius Shakhtour, et al.
Scientific Reports|May 24, 2020
Increased alpha-synuclein tear fluid levels in patients with Parkinson's diseaseFabian Maass, Sebastian Rikker, Vivian Dambeck, et al.
Der Nervenarzt|May 6, 2020
[CANVAS: case report on a novel repeat expansion disorder with late-onset ataxia]Tobias Meindl, Isabell Cordts, Anna-Lisa Scherzer, et al.
Neurobiology of Disease|October 7, 2014
AAV.shRNA-mediated downregulation of ROCK2 attenuates degeneration of dopaminergic neurons in toxin-induced models of Parkinson's disease in vitro and in vivoKim-Ann Saal, Jan C Koch, Lars Tatenhorst, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 17, 2010
Mechanisms of acute axonal degeneration in the optic nerve in vivoJohanna Knöferle, Jan C Koch, Thomas Ostendorf, et al.
Pageof 18

Showing results (81-90 of 173) with videos related to

Sort By:
Pageof 18
Frontiers in Aging Neuroscience|October 11, 2021
Detection of Cerebrospinal Fluid Neurofilament Light Chain as a Marker for Alpha-SynucleinopathiesSezgi Canaslan, Matthias Schmitz, Anna Villar-Piqué, et al.
Molecular Therapy. Nucleic Acids|June 3, 2018
miR-182-5p and miR-183-5p Act as GDNF Mimics in Dopaminergic Midbrain NeuronsAnna-Elisa Roser, Lucas Caldi Gomes, Rashi Halder, et al.
ACS Chemical Neuroscience|August 19, 2015
Alpha-Synuclein Regulates Neuronal Levels of Manganese and CalciumTanja Dučić, Eleonora Carboni, Barry Lai, et al.
Brain : a Journal of Neurology|October 23, 2012
Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson's diseaseLars Tönges, Tobias Frank, Lars Tatenhorst, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|April 16, 2022
Blood-based biomarker in Parkinson's disease: potential for future applications in clinical research and practiceLars Tönges, Carsten Buhmann, Stephan Klebe, et al.
Plos One|January 29, 2026
Retrospective analysis of neurofilament-light chain in patients with inflammatory bowel disease - A pilot studyAndreas Wolff, Emily Feneberg, Julius Shakhtour, et al.
Scientific Reports|May 24, 2020
Increased alpha-synuclein tear fluid levels in patients with Parkinson's diseaseFabian Maass, Sebastian Rikker, Vivian Dambeck, et al.
Der Nervenarzt|May 6, 2020
[CANVAS: case report on a novel repeat expansion disorder with late-onset ataxia]Tobias Meindl, Isabell Cordts, Anna-Lisa Scherzer, et al.
Neurobiology of Disease|October 7, 2014
AAV.shRNA-mediated downregulation of ROCK2 attenuates degeneration of dopaminergic neurons in toxin-induced models of Parkinson's disease in vitro and in vivoKim-Ann Saal, Jan C Koch, Lars Tatenhorst, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 17, 2010
Mechanisms of acute axonal degeneration in the optic nerve in vivoJohanna Knöferle, Jan C Koch, Thomas Ostendorf, et al.
Pageof 18